1. Home
  2. PTEN vs CPRX Comparison

PTEN vs CPRX Comparison

Compare PTEN & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Patterson-UTI Energy Inc.

PTEN

Patterson-UTI Energy Inc.

HOLD

Current Price

$9.28

Market Cap

3.6B

Sector

Energy

ML Signal

HOLD

Logo Catalyst Pharmaceuticals Inc.

CPRX

Catalyst Pharmaceuticals Inc.

HOLD

Current Price

$31.48

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PTEN
CPRX
Founded
1978
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
3.9B
IPO Year
1995
2006

Fundamental Metrics

Financial Performance
Metric
PTEN
CPRX
Price
$9.28
$31.48
Analyst Decision
Buy
Strong Buy
Analyst Count
10
1
Target Price
$10.80
$35.00
AVG Volume (30 Days)
10.5M
1.8M
Earning Date
04-22-2026
05-11-2026
Dividend Yield
3.24%
N/A
EPS Growth
90.16
28.24
EPS
N/A
0.50
Revenue
$4,826,624,000.00
$119,072,803.00
Revenue This Year
N/A
$9.20
Revenue Next Year
$4.34
$10.51
P/E Ratio
N/A
$62.97
Revenue Growth
N/A
16.39
52 Week Low
$5.10
$19.05
52 Week High
$13.08
$32.56

Technical Indicators

Market Signals
Indicator
PTEN
CPRX
Relative Strength Index (RSI) 41.13 69.77
Support Level $9.26 $31.25
Resistance Level $12.59 $32.56
Average True Range (ATR) 0.42 0.04
MACD 0.03 -0.06
Stochastic Oscillator 49.13 85.71

Price Performance

Historical Comparison
PTEN
CPRX

About PTEN Patterson-UTI Energy Inc.

Patterson-UTI Energy Inc is a Texas based provider of drilling and completion services to oil and natural gas exploration and production companies, offering contract drilling, integrated well completion, directional drilling services, and specialized drill bit solutions. The Company operates through three segments: Drilling Services, Completion Services, and Drilling Products. Drilling Services includes contract and directional drilling, Completion Services generates maximum revenue and includes hydraulic fracturing and related support services, and Drilling Products includes the manufacturing and distribution of drill bits. The Company operates in the United States, Canada, Colombia, and Other Countries, with the majority of revenue coming from the United States.

About CPRX Catalyst Pharmaceuticals Inc.

Catalyst Pharmaceuticals Inc is a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare and difficult to treat diseases. The Company sells three commercial stage drug products, FIRDAPSE (amifampridine), AGAMREE (vamorolone), and FYCOMPA (perampanel). The Company is currently seeking to further expand its product portfolio, with a focus on acquiring the rights to immediately and near-term accretive assets to treat rare (orphan) diseases across therapeutic areas, including clinical-stage opportunities with established proof of concept.

Share on Social Networks: